PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hidden genetic causes of congenital heart disease identified

New approach uncovers genetic interactions contributing to heart defects

Hidden genetic causes of congenital heart disease identified
2025-02-20
(Press-News.org) New York, NY [February 20, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect. Details on their findings were reported in the February 20 online issue of The American Journal of Human Genetics [DOI: 10.1016/j.ajhg.2025.01.024].

“Our research reveals the potential for digenic inheritance—where two genes work together to cause disease—expanding our understanding of the genetic underpinnings of congenital heart disease,” says co-corresponding senior author Yuval Itan, PhD, Associate Professor of Genetics and Genomic Sciences, a core member of The Charles Bronfman Institute for Personalized Medicine, and a member of The Mindich Child Health and Development Institute at the Icahn School of Medicine at Mount Sinai. He co-supervised the study with Bruce Gelb, MD, Gogel Family Professor and Director of The Mindich Institute. “By identifying these gene pairs and their combined effects, we uncover previously hidden genetic risks, which could improve diagnostic precision and open new avenues for personalized treatment strategies.”

Congenital heart disease is the most common congenital anomaly, affecting millions worldwide. Despite decades of research, more than half of CHD cases still lack a molecular diagnosis. By analyzing trio exome sequencing data from affected and unaffected children in the Pediatric Genomic Consortium (PCGC), the team identified 10 novel gene pairs potentially linked to the development of CHD.

“Our work demonstrates that genetic interactions, rather than single-gene causes alone, could play a significant role in congenital heart disease. By developing a method to uncover these interactions, we are broadening the scope of genetic research, which could lead to improved diagnosis, enhanced risk assessment, and more informed genetic counseling,” says first author Meltem Ece Kars, MD, PhD, a postdoctoral fellow in The Bronfman Institute. “As clinical genetic testing advances, integrating digenic models could significantly improve diagnostic yield, offering patients and their families greater clarity about their condition and guiding the development of targeted therapies and interventions.”

The research team used a robust computational method to identify gene pairs that may act together to cause CHD. This innovative approach could transform how genetic studies are conducted for complex diseases, providing deeper insights into the role of genetics in disease development, say the investigators.

The study also paves the way for advancing genetic diagnoses in other complex disorders. “With the tools we’ve developed, our research provides a framework for future studies into genetic interactions that could affect a wide range of human diseases,” says Dr. Itan.

Next, the researchers plan to apply the digenic approach to other disease groups that have traditionally been studied using the monogenic model, potentially explaining some of the missing heritability in these disorders. Ultimately, they aim to extend the digenic approach into a robust polygenic framework capable of identifying multiple disease-causing variants and genes in patients.

“Our findings hold promise for improving genetic diagnoses, offering better risk assessments, and ultimately guiding more personalized treatments for individuals with congenital heart disease,” says Dr. Kars.

The paper is titled “Deciphering the digenic architecture of congenital heart disease using trio exome sequencing data.”

The remaining authors are David Stein (PhD student at the Icahn School of Medicine at Mount Sinai); Peter D. Stenson, (Cardiff University, UK); David N. Cooper, PhD (Cardiff University, UK); Wendy K. Chung, MD, PhD (Boston Children’s Hospital and Harvard Medical School); Peter J. Gruber, MD, PhD (Yale School of Medicine); Christine E. Seidman, MD, (Harvard Medical School, Brigham and Women's Hospital, Howard Hughes Medical Institute); Yufeng Shen, PhD (Columbia University Irving Medical Center); and Martin Tristani-Firouzi, MD (University of Utah School of Medicine).

This research is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the U.S. Department of Health and Human Services through grants UM1HL128711, UM1HL098162, UM1HL098147, UM1HL098123, UM1HL128761, and U01HL131003. Additional support was provided by Clinical and Translational Science Awards (CTSA) grant UL1TR004419 from the National Center for Advancing Translational Sciences.

-####-

 

About the Icahn School of Medicine at Mount Sinai 

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.  

The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 500 postdoctoral research fellows. 

Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges.  More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.

------------------------------------------------------- 

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.  

 

 

 

 

 

 

 

END


[Attachments] See images for this press release:
Hidden genetic causes of congenital heart disease identified

ELSE PRESS RELEASES FROM THIS DATE:

Semaglutide and nonarteritic anterior ischemic optic neuropathy

2025-02-20
About The Study: The results of this study suggest a modest increase in the risk of nonarteritic anterior ischemic optic neuropathy among individuals with type 2 diabetes associated with semaglutide use, smaller than that previously reported, and warranting further investigation into the clinical implications of this association.  Corresponding Author: To contact the corresponding author, Cindy X. Cai, MD, MS, email ccai6@jhmi.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaophthalmol.2024.6555) Editor’s ...

Inequities in the application of behavioral flags for hospitalized pediatric patients

2025-02-20
About The Study: This cohort study found significant inequities in incidence of behavioral flags in the electronic health record among racially and socioeconomically marginalized pediatric patients. This finding was most pronounced for Black or African American patients younger than 8 years, suggesting that this phenomenon may be a response to Black families rather than specific patient behavior. Corresponding Author: To contact the corresponding author, April Edwell, MD, MAEd, email April.edwell@ucsf.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.61079) Editor’s ...

Paxlovid’s impact on hospitalization and death in COVID-vaccinated older adults far weaker than previously thought

2025-02-20
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research. The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults. Pfizer’s 2022 clinical trial found reduced COVID-19 hospitalization in unvaccinated middle-aged adults; while a subsequent 2024 clinical trial found no significant reduction in vaccinated middle-aged adults. Since most older Americans have already received two or more COVID-19 vaccines, Paxlovid’s effectiveness on vaccinated ...

Additive manufacturing of biomedical metals for medical implant fabrication

Additive manufacturing of biomedical metals for medical implant fabrication
2025-02-20
Biomedical metal implant materials are widely used in clinical applications, including dental implants, hip replacement, bone plates, and screws. However, traditional manufacturing processes face limitations in meeting customized medical needs, internal structural control, and efficient material utilization. For example, when producing complex-shaped titanium alloy parts using conventional methods, the material consumption ratio is as high as 10:1-20:1, leading to significant material waste. As a result, ...

Antioxidant-enzyme Interaction in non-communicable diseases

2025-02-20
Introduction Oxidative stress, caused by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, plays a central role in the development of non-communicable diseases (NCDs). These diseases, including cardiovascular disorders, diabetes, neurodegenerative conditions, cancer, and liver and kidney diseases, are among the leading causes of morbidity and mortality worldwide. Enzymatic and non-enzymatic antioxidants serve as the body’s primary defense against ROS, maintaining redox homeostasis and preventing cellular damage. However, when ROS levels exceed the capacity of antioxidant defenses, oxidative stress ensues, contributing ...

Turtles change nesting patterns in response to climate change

Turtles change nesting patterns in response to climate change
2025-02-20
New research shows that turtles are responding to climate change by nesting earlier. Researchers monitoring nesting green and loggerhead turtles in Cyprus have discovered they are returning to their regular nesting spots earlier each year to compensate for rising temperatures. In sea turtles, temperature determines the biological sex of offspring, with more females born when it is warmer, as well as fewer successful hatchings when it gets too hot. Turtles also have “natal philopatry”, which means they return to nest in the area where they themselves hatched. A research team from the University of Exeter and the Society for the Protection of ...

New research links grape consumption to improved muscle health in both men and women

2025-02-20
A new study from Western New England University (WNE) has revealed that long-term grape consumption significantly impacts muscle health, with notable benefits for both men and women. The research, published in the journal Foods, suggests that a diet including grapes can modify gene expression in muscle, potentially offering a new nutritional strategy for maintaining muscle mass and function.  Around 30 million tons of grapes are consumed every year, and their benefits extend beyond nutrition. Grapes have been shown to ...

Both sides of the coin: Lack of consensus on continuing vs. discontinuing opioid medications prescriptions for adults with chronic pain

2025-02-20
INDIANAPOLIS – Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help some patients. With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain. The authors analyzed the opinions of 28 experts on the harms versus benefits of maintaining, tapering or terminating opioid pain medication prescriptions ...

National Academy of Inventors welcomes 162 emerging inventors

2025-02-20
The National Academy of Inventors (NAI) has announced the 2025 class of Senior Members, comprised of 162 emerging inventors from NAI’s Member Institutions. This year’s class of NAI Senior Members is the largest to date and hails from 64 NAI Member Institutions across the nation. Collectively, they are named inventors on over 1200 U.S. patents.  “To see this program grow year over year is a testament to the dedication our Member Institutions have to fostering innovation on their campuses and supporting their inventive staff ...

Narcissists more likely to feel ostracized

2025-02-20
Narcissists feel ostracized more frequently than their less self-absorbed peers, according to research published by the American Psychological Association. This may stem not only from being shunned due to their personalities but from a tendency to misinterpret ambiguous social signals as exclusion.     “Feeling ostracized is a subjective experience based on the perception of social cues by the individual. Some may be intentionally ostracized, while others may merely believe they are being excluded when that’s not the case,” said lead author Christiane Büttner, PhD, of the University of Basel. “Our findings suggest that ...

LAST 30 PRESS RELEASES:

Precision therapy with microbubbles

LLM-based web application scanner recognizes tasks and workflows

Pattern of compounds in blood may indicate severity of gestational hypertension and preeclampsia

How does innovation policy respond to the challenges of a changing world?

What happens when a diet targets ultra-processed foods?

University of Vaasa, Finland, conducts research on utilizing buildings as energy sources

Stealth virus: Zika virus builds tunnels to covertly infect cells of the placenta

The rising tide of sand mining: a growing threat to marine life

Contemporary patterns of end-of-life care among Medicare beneficiaries with advanced cancer

Digital screen time and nearsightedness

Postoperative weight loss after anti-obesity medications and revision risk after joint replacement

New ACS research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

New frailty measurement tool could help identify vulnerable older adults in epic

Co-prescribed stimulants, opioids linked to higher opioid doses

What if we could revive waste carbon dioxide?

Mechanochemistry strikes again – A facile means for generating organolithium molecules

Breakthrough in high-performance oxide-ion conductors using rubidium

Hurricane-proofed downtown skyscrapers unexpectedly vulnerable to ‘bouncing’ winds

Microcomb chips help pave the way for thousand times more accurate GPS systems

Illuminating the proton’s inner workings

Genetic therapy gives infants life-changing improvements in sight

Impacts of workplace bullying on sleep can be “contagious” between partners

UK peatland fires are supercharging carbon emissions as climate change causes hotter, drier summers

Coastal erosion threatens this ancient city — and others much closer to home

Walgreens supports the American Heart Association to bring CPR to communities nationwide

How mosquitos hear may inspire new ways to detect natural disasters

Child ADHD risk linked to mother’s use of acetaminophen

New solution to help therapy ‘dropouts’

New AI system accurately maps urban green spaces, exposing environmental divides

Gordon Keller receives the 2025 ISSCR Achievement Award for his seminal work in regenerative medicine

[Press-News.org] Hidden genetic causes of congenital heart disease identified
New approach uncovers genetic interactions contributing to heart defects